14 小时
inews.co.uk on MSNThe future of weight loss drugs: gummies, tablets and melt-in-the-mouth stripsThe race is on to make the first oral weight loss medicines, but smaller US pharmacies may have already got there – if they ...
Discover top medications for 'treating Type 2 Diabetes'? This page compiles essential information on generic and brand-name drugs specifically used for Type 2 Diabetes treatment.Here, you can ...
16 天
India Today on MSNMankind Pharma launches generic for popular diabetes drug at one-tenth the costMankind Pharma and other domestic companies have launched generic versions of the popular diabetes drug Empagliflozin at one-tenth of the original cost.
8 天
India Today on MSNMounjaro, popular weight-loss drug, launched in India. Here's how much it costsPopular anti-diabetes and obesity drug Mounjaro, containing the active ingredient tirzepatide, is now available in India in a ...
2 天
GMA Network on MSNUP Manila develops herbal tablet for diabetes managementCiting diabetes as the fourth leading cause of death and affecting approximately 4.4 million Filipinos, the researchers led by Assistant Professor Raymond Fernando Yu aims "to provide a locally ...
Type 2 diabetes is the most common kind of diabetes. Lifestyle factors such as diet and exercise, genetics, and some medications can cause you to develop the condition. It’s sometimes called ...
Homegrown pharmaceutical companies launching significantly cheaper generic versions of empagliflozin—a widely prescribed ...
Eli Lilly launches diabetes and obesity drug Mounjaro in India, offering innovative treatment for metabolic health management ...
Semaglutide is a drug used for weight loss. Oral tablets and injections are both effective ways to take semaglutide. Oral tablets do not require the use of needles, but you may need to take them ...
The onset of diabetes is most common in people ages 45 to 64. Type 2 diabetes is the most common form of diabetes. It usually appears after the age of 45 but can occur at any age. The development ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果